Dec 17, 2015 11:30am EST Adaptimmune Announces Initiation of Study to Evaluate its New Affinity Enhanced T-Cell Therapy Targeting MAGE-A10 in Patients With NSCLC, the Most Common Form of Lung Cancer
Dec 01, 2015 7:00am EST Adaptimmune and Universal Cells Announce Collaboration to Develop Allogeneic T-Cell Therapies
Nov 24, 2015 11:15am EST Adaptimmune Initiates Phase I / II Trial Evaluating Its Affinity Enhanced T-Cell Therapy Targeting NY-ESO-1 in Patients With the Most Common Type of Lung Cancer
Nov 12, 2015 10:17am EST Adaptimmune to Participate in the Jefferies Autumn 2015 Global Healthcare Conference
Nov 05, 2015 8:15am EST Adaptimmune Announces Data From Clinical Study of NY-ESO Affinity Enhanced T-Cell Therapy in Synovial Sarcoma at the 2015 Annual Meeting of the Society of Immunotherapy for Cancer (SITC)
Oct 30, 2015 9:00am EDT Adaptimmune Announces Upcoming Data Presentation at the 2015 Annual Meeting of the Society of Immunotherapy for Cancer (SITC)
